These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22321466)

  • 1. Management of overt hepatic encephalopathy.
    Khungar V; Poordad F
    Clin Liver Dis; 2012 Feb; 16(1):73-89. PubMed ID: 22321466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic encephalopathy.
    Khungar V; Poordad F
    Clin Liver Dis; 2012 May; 16(2):301-20. PubMed ID: 22541700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on management of patients with overt hepatic encephalopathy.
    Chacko KR; Sigal SH
    Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and management of hepatic encephalopathy.
    Sargent S
    Br J Nurs; 2007 Mar 22-Apr 11; 16(6):335-9. PubMed ID: 17505386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.
    Kodali S; McGuire BM
    Clin Liver Dis; 2015 Aug; 19(3):565-76. PubMed ID: 26195209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging strategies for treating hepatic encephalopathy.
    Foster KJ; Lin S; Turck CJ
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):341-50. PubMed ID: 20691385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms, diagnosis and management of hepatic encephalopathy.
    Prakash R; Mullen KD
    Nat Rev Gastroenterol Hepatol; 2010 Sep; 7(9):515-25. PubMed ID: 20703237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy: how to test and treat.
    Rahimi RS; Rockey DC
    Curr Opin Gastroenterol; 2014 May; 30(3):265-71. PubMed ID: 24717765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and treatment of minimal hepatic encephalopathy.
    Zhan T; Stremmel W
    Dtsch Arztebl Int; 2012 Mar; 109(10):180-7. PubMed ID: 22470407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and treatment of hepatic encephalopathy].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for hyperammonemia.
    Hadjihambi A; Khetan V; Jalan R
    Expert Opin Pharmacother; 2014 Aug; 15(12):1685-95. PubMed ID: 25032885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifaximin for treatment of hepatic encephalopathy.
    Maclayton DO; Eaton-Maxwell A
    Ann Pharmacother; 2009 Jan; 43(1):77-84. PubMed ID: 19092143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy.
    Direkze S; Jalan R
    Dig Dis; 2015; 33(4):562-9. PubMed ID: 26159274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.